MICHAEL OVERCASH: Open Payments
NPI 1376520171 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$41,681 in 191 payments from 22 companies in 2025. Trend: 2023 $70,706 · 2024 $53,200 · 2025 $41,681
Speaker / faculty: $27,403Consulting: $5,960Food & beverage: $4,318Travel & lodging: $3,849Education: $152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $22,109 |
| Arcutis Biotherapeutics, Inc. | 18 | $9,102 |
| Incyte Corporation | 22 | $4,239 |
| Kowa Pharmaceuticals America, Inc. | 3 | $2,324 |
| E.R. Squibb & Sons, L.L.C. | 7 | $1,590 |
| Novartis Pharmaceuticals Corporation | 13 | $307 |
| GENZYME CORPORATION | 10 | $278 |
| ABBVIE INC. | 12 | $254 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $241 |
| Galderma Laboratories, L.P. | 13 | $207 |
Products named: TREMFYA, Zoryve, Opzelura, Sotyktu, DUPIXENT, COSENTYX, NEMLUVIO, RINVOQ.
Industry payments across SC — which companies pay providers there.
